Medical device firm Therox files for $100 mln IPO
WASHINGTON, Sept 4 (Reuters) - Therox Inc, a medical device company focused on treating oxygen deprived tissue, said on Thursday it is planning an initial public offering of as much as $100 million in common stock.
Citi, UBS Investment Bank, Cowen and Company, and Wachovia Securities will underwrite the IPO, according to a preliminary offering document filed with the Securities and Exchange Commission.
The company is seeking a Nasdaq listing under the symbol "THER." (Editing by Andre Grenon)
© Thomson Reuters 2008 All rights reserved
Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.
Have a correction to this article? Email the editors
Rockefeller Center Tree lighting